A Study of GFH375 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors Harboring KRAS G12D Mutation

Clinical trial NCT07259590 · RECRUITING

Trial details

NCT number: NCT07259590
Sponsor: Genfleet Therapeutics (Shanghai) Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors Cancer PDAC CRC (Colorectal Cancer)

Start date: 2025-10-21
Primary completion: 2027-07-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.